Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide versus placebo as adjunctive therapy for primary generalized tonic-clonic seizures in idiopathic generalized epilepsy
MOH_2017-03-01_000193Phase 3Recruiting
- Sponsor
- UCB
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lacosamide in idiopathic epilepsy (IGE) (2 arms), sponsored by UCB. Primary endpoint: Primary endpoint not reported. Started Aug 2015; status: recruiting.
02
Drugs
lacosamide
03
Conditions
idiopathic epilepsy (IGE)
Beyond the preview
Go deeper on MOH_2017-03-01_000193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-03-01_000193.